Wells Fargo
AURA icon

Wells Fargo’s Aura Biosciences AURA Stock Holding History

Wells Fargo’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Buy
40,918
+23,924
+141% +$171K ﹤0.01% 4964
2026
Q1 		$114K Sell
16,994
-32,059
-65% -$184K ﹤0.01% 5036
2025
Q4 		$267K Buy
49,053
+17,342
+55% +$103K ﹤0.01% 4904
2025
Q3 		$196K Buy
31,711
+8,962
+39% +$58.6K ﹤0.01% 4942
2025
Q2 		$142K Sell
22,749
-5,490
-19% -$32.1K ﹤0.01% 4974
2025
Q1 		$165K Buy
28,239
+616
+2% +$4.66K ﹤0.01% 4826
2024
Q4 		$227K Buy
27,623
+5,930
+27% +$55.8K ﹤0.01% 4723
2024
Q3 		$193K Buy
21,693
+914
+4% +$7.84K ﹤0.01% 4603
2024
Q2 		$157K Buy
20,779
+7,764
+60% +$56.9K ﹤0.01% 4665
2024
Q1 		$102K Buy
13,015
+4,399
+51% +$36.5K ﹤0.01% 4887
2023
Q4 		$76.3K Buy
8,616
+1,841
+27% +$15.6K ﹤0.01% 5073
2023
Q3 		$60.8K Sell
6,775
-3,655
-35% -$39.3K ﹤0.01% 5076
2023
Q2 		$129K Buy
10,430
+5,869
+129% +$62.7K ﹤0.01% 4873
2023
Q1 		$42.3K Buy
+4,561
New +$47.4K ﹤0.01% 5252
2022
Q4 		– Sell
-310
Closed -$6K – 7460
2022
Q3 		$6K Sell
310
-120
-28% -$1.82K ﹤0.01% 5841
2022
Q2 		$6K Sell
430
-791
-65% -$13.1K ﹤0.01% 5930
2022
Q1 		$27K Sell
1,221
-2,047
-63% -$39K ﹤0.01% 5899
2021
Q4 		$55K Buy
+3,268
New +$58.4K ﹤0.01% 5927

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Wells Fargo's AURA Position: Q2 2026 in Review

Wells Fargo increased its Aura Biosciences (AURA) stake by 141% in Q2 2026, buying an estimated $171K and bringing the position to 40,918 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #4964.

Wells Fargo first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Wells Fargo held 40,918 shares of Aura Biosciences worth $291K as of Q2 2026.
  • Wells Fargo bought 23,924 Aura Biosciences shares in Q2 2026, an estimated $171K.
  • Aura Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4964 holding.
  • Wells Fargo first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.